Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Jan 15, 2019; 11(1): 39-47
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.39
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.39
Characteristic | Total (n = 303) |
Age, yr | |
< 60 | 150 (49.5) |
≥ 60 | 103 (50.5) |
Sex | |
Female | 135 (44.55) |
Male | 168 (55.46) |
Infectious diseases | |
HBV | 31 (10.23) |
HCV | 5 (1.65) |
Serum albumin level [median (cIQ values)] | 38.7 (25.0 - 49.0) |
ALP [median (IQ values)] | 315 (42.0 - 6778.0) |
AAPR | |
≥ 0.41 | 253 (83.5) |
< 0.41 | 50 (16.5) |
Tumor size | |
< 3 | 233 (76.9) |
≥ 3 | 70 (23.1) |
Number of tumors | |
1 | 278 (91.7) |
≥ 2 | 25 (8.3) |
Curative resection | 156 (51.5) |
Stage (III + IV) | 98 (32.3) |
- Citation: Xiong JP, Long JY, Xu WY, Bian J, Huang HC, Bai Y, Xu YY, Zhao HT, Lu X. Albumin-to-alkaline phosphatase ratio: A novel prognostic index of overall survival in cholangiocarcinoma patients after surgery. World J Gastrointest Oncol 2019; 11(1): 39-47
- URL: https://www.wjgnet.com/1948-5204/full/v11/i1/39.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i1.39